Association between smoking status, toxicity and survival in the checkpoint inhibitor immunotherapy
The results suggested that smoking, measured in pack-years, had no appreciable effect on the amount of toxicity experienced by patients and no correlation between smoking status, irAEs and efficiency of the treatment was found. Despite results not reaching statistical significance, other potential mechanisms by which smoking may influence cancer treatment cannot be ruled out.
Authors
- Katarzyna Machulska-Ciuraj
- Mariola Janiszewska (ORCID: https://orcid.org/0000-0002-7116-6783)
- Anna Rodzajewska (ORCID: https://orcid.org/0000-0001-6204-770X)
- Sławomir Mańdziuk (ORCID: https://orcid.org/0000-0002-9812-0777)
- Jakub Oberda
- Katarzyna Szklener (ORCID: https://orcid.org/0000-0001-8033-3574)
- Pola Juchaniuk
- Monika Rychlik-Grabowska
- Anna Rudzińska (ORCID: https://orcid.org/0000-0002-8901-6222)
- Kamila Krukowska (ORCID: https://orcid.org/0009-0006-8445-5660)
- Sylwia Krzyśkowska
- Eliza Kuchta
- Aleksandra Urniaż
- Rafał Urniaż
Institutions
- Medical University of Lublin (PL)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-11-25
- DOI
- https://doi.org/10.3389/fonc.2024.1459608
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.57